Pharmacokinetic (Pk) And Exposure-Response (Er) Analysis Of Pertuzumab (P) In Patients (Pts) With Her2-Positive Metastatic Gastroesophageal Junction And Gastric Cancer (Mgejc/Gc).
JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要